ANALYSIS OF THE RESULTS OF TOFACITINIB THERAPY IN REAL CLINICAL PRACTICE ACCORDING TO THE ALL-RUSSIAN ARTHRITIS REGISTRY (OREL)

Objective: to analyze the results of tofacitinib (TOFA) therapy in real clinical practice according to the All-Russian Arthritis Registry (OREL). Subjects and methods. The OREL Registry included 347 patients (286 (82%) women and 61 (18%) men) with rheumatoid arthritis (RA) who initiated TOFA therapy...

詳細記述

書誌詳細

出版年:	Научно-практическая ревматология
主要な著者:	A. S. Avdeeva, A. S. Misiyuk, A. M. Satybaldyev, G. V. Lukina, V. N. Sorotskaya, E. V. Zhilyaev, A. R. Babaeva, A. A. Baranov, V. I. Mazurov, I. N. Shendrygin, T. S. Salnikova, L. A. Knyazeva, D. G. Krechikova, R. R. Samigullina, I. Z. Gaidukova, D. I. Abdulganieva, I. N. Kushnir, O. N. Anoshenkova, N. A. Lapkina, E. A. Koshkarova, A. M. Lila, E. L. Nasonov
フォーマット:	論文
言語:	ロシア語
出版事項:	IMA PRESS LLC 2020-06-01
主題:	rheumatoid arthritis orel registry tofacitinib disease activity real clinical practice
オンライン･アクセス:	https://rsp.mediar-press.net/rsp/article/view/2891